Joshua T. Brumm
Net Worth

Last updated:

What is Joshua T. Brumm net worth?

The estimated net worth of Mr. Joshua T. Brumm is at least $36,427,549 as of 11 Mar 2024. He owns shares worth $6,590,476 as insider, has earned $26,679,313 from insider trading and has received compensation worth at least $3,157,760 in Dyne Therapeutics, Inc..

What is the salary of Joshua T. Brumm?

Mr. Joshua T. Brumm salary is $789,440 per year as Chief Executive Officer, Pres & Director in Dyne Therapeutics, Inc..

How old is Joshua T. Brumm?

Mr. Joshua T. Brumm is 47 years old, born in 1978.

What stocks does Joshua T. Brumm currently own?

As insider, Mr. Joshua T. Brumm owns shares in one company:

Company Title Shares Price per share Total value
Dyne Therapeutics, Inc. (DYN) Chief Executive Officer, Pres & Director 537,998 $12.25 $6,590,476

What does Dyne Therapeutics, Inc. do?

Dyne Therapeutics, Inc., a muscle disease company, operates as a biotechnology company that focuses on advancing therapeutics for genetically driven muscle diseases in the United States. It develops various programs for myotonic dystrophy type 1, duchenne muscular dystrophy, and facioscapulohumeral dystrophy, as well as rare skeletal muscle, and cardiac and metabolic muscle diseases using its FORCE platform that delivers disease-modifying therapeutics. The company was incorporated in 2017 and is headquartered in Waltham, Massachusetts..

Joshua T. Brumm insider trading

Dyne Therapeutics, Inc.

Mr. Joshua T. Brumm has made 31 insider trades between 2021-2024, according to the Form 4 filled with the SEC.

The largest trade he's ever made was exercising 209,412 units of DYN stock on 8 Mar 2024. As of 11 Mar 2024 he still owns at least 537,998 units of DYN stock.

Transaction Date Security Shares Price per share Total value Source
Option
Stock option (right to buy) 50,000 $5.54 $277,000
Sale
Common Stock 7,769 $26.12 $202,926
Sale
Common Stock 9,928 $26.1 $259,121
Sale
Common Stock 40,072 $25.42 $1,018,630
Sale
Common Stock 8,618 $25.93 $223,465
Option
Common Stock 50,000 $5.54 $277,000
Option
Common Stock 153,931 $5.54 $852,778
Option
Stock option (right to buy) 153,931 $5.54 $852,778
Sale
Common Stock 435 $27.38 $11,910
Sale
Common Stock 202,238 $25.3 $5,116,621
Sale
Common Stock 160,670 $26.72 $4,293,102
Option
Stock option (right to buy) 209,412 $5.54 $1,160,142
Option
Common Stock 209,412 $5.54 $1,160,142
Sale
Common Stock 9,086 $25.85 $234,873
Sale
Common Stock 1,414 $29.7 $41,996
Option
Stock option (right to buy) 57,843 $5.54 $320,450
Sale
Common Stock 18,976 $28.25 $536,072
Sale
Common Stock 74,090 $29.23 $2,165,651
Option
Common Stock 94,480 $5.54 $523,419
Option
Stock option (right to buy) 36,637 $5.54 $202,969
Option
Common Stock 5,520 $5.54 $30,581
Sale
Common Stock 5,520 $27.5 $151,800
Option
Stock option (right to buy) 5,520 $5.54 $30,581
Option
Stock option (right to buy) 18,536 $1.03 $19,092
Option
Stock option (right to buy) 200,000 $5.54 $1,108,000
Option
Common Stock 18,536 $1.03 $19,092
Option
Common Stock 200,000 $5.54 $1,108,000
Sale
Common Stock 38,301 $19.05 $729,634
Sale
Common Stock 180,235 $18.4 $3,316,324
Sale
Common Stock 16,026 $20.5 $328,533
Sale
Common Stock 19,775 $19.03 $376,318
Sale
Common Stock 15,382 $18.34 $282,106
Option
Common Stock 51,183 $1.03 $52,718
Option
Stock option (right to buy) 51,183 $1.03 $52,718
Sale
Common Stock 7,585 $10.72 $81,311
Sale
Common Stock 12,032 $9.41 $113,221
Sale
Common Stock 7,672 $10.41 $79,866
Sale
Common Stock 187,748 $12.61 $2,367,502
Option
Common Stock 171,360 $1.03 $176,501
Option
Stock Option (right to buy) 171,360 $1.03 $176,501
Option
Common Stock 76,582 $1.03 $78,879
Option
Stock Option (right to buy) 76,582 $1.03 $78,879
Sale
Common Stock 76,582 $13.34 $1,021,604
Sale
Common Stock 46,811 $13.15 $615,565
Option
Common Stock 30,088 $1.03 $30,991
Option
Stock Option (right to buy) 30,088 $1.03 $30,991
Sale
Common Stock 14,189 $13.47 $191,126
Sale
Common Stock 7,318 $13.33 $97,549
Sale
Common Stock 3,322 $10.87 $36,110
Sale
Common Stock 195,800 $12.46 $2,439,668
Option
Stock Option (right to buy) 195,800 $1.03 $201,674
Option
Common Stock 195,800 $1.03 $201,674
Sale
Common Stock 14,200 $13.37 $189,854
Option
Stock Option (right to buy) 14,200 $1.03 $14,626
Option
Common Stock 14,200 $1.03 $14,626
Sale
Common Stock 3,384 $8.73 $29,542
Sale
Common Stock 4,584 $16.11 $73,848
Sale
Common Stock 3,425 $15.61 $53,464

Dyne Therapeutics key executives

Dyne Therapeutics, Inc. executives and other stock owners filed with the SEC: